Abstract:The immune system defends against invading pathogens through the rapid activation of innate immune signaling pathways. Interferon regulatory factor 3 (IRF3) is a key transcription factor activated in response to virus infection and is largely responsible for establishing an antiviral state in the infected host. Studies in Irf3−/− mice have demonstrated the absence of IRF3 imparts a high degree of susceptibility to a wide range of viral infections. Virus infection causes the activation of IRF3 to transcribe type-I interferon (e.g., IFNβ), which is responsible for inducing the interferon-stimulated genes (ISGs), which act at specific stages to limit virus replication. In addition to its transcriptional function, IRF3 is also activated to trigger apoptosis of virus-infected cells, as a mechanism to restrict virus spread within the host, in a pathway called RIG-I-like receptor-induced IRF3 mediated pathway of apoptosis (RIPA). These dual functions of IRF3 work in concert to mediate protective immunity against virus infection. These two pathways are activated differentially by the posttranslational modifications (PTMs) of IRF3. Moreover, PTMs regulate not only IRF3 activation and function, but also protein stability. Consequently, many viruses utilize viral proteins or hijack cellular enzymes to inhibit IRF3 functions. This review will describe the PTMs that regulate IRF3′s RIPA and transcriptional activities and use coronavirus as a model virus capable of antagonizing IRF3-mediated innate immune responses. A thorough understanding of the cellular control of IRF3 and the mechanisms that viruses use to subvert this system is critical for developing novel therapies for virus-induced pathologies.

Community series in identification, function, and mechanisms of interferon induced genes associated with viruses, volume II

Research progress towards interferon stimulated genes and its clinical signifi-cance

Interferon Independent Non-Canonical Stat Activation And Virus Induced Inflammation

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling

Interferon-Stimulated Genes: What Do They All Do?

Transcriptional Regulation of Antiviral Interferon-Stimulated Genes

Interference without interferon: interferon-independent induction of interferon-stimulated genes and its role in cellular innate immunity

Interferon-stimulated genes and their antiviral activity against SARS-CoV-2

Interferons: signaling, antiviral and viral evasion

Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism

Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections

Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases

Interferons in Viral Infections

Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity

Research progress in the interaction between interferon-stimulated genes and SARS-CoV-2

The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies

Intracellular innate immunity and mechanism of action of cytosolic nucleic acid receptor‐mediated type I IFN against viruses

Interferon Induction by Rna Viruses and Antagonism by Viral Pathogens

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways

Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape